BECN1 and invasive carcinoma: Immunoreactivity of the anti-beclin-1 antibody was observed in the cancer cells of 68 of 115 tissue specimens and in the mesenchymal stromal cells of 38 of 115 invasive carcinoma tissue specimens (Fig 2).